{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T14:38:35Z","timestamp":1786804715695,"version":"build-2736575974"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2020,6,1]]},"DOI":"10.1001\/jamaoncol.2020.1052","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T15:03:17Z","timestamp":1588863797000},"page":"895","source":"Crossref","is-referenced-by-count":73,"title":["Olanzapine for the Treatment of Advanced Cancer\u2013Related Chronic Nausea and\/or Vomiting"],"prefix":"10.1001","volume":"6","author":[{"given":"Rudolph M.","family":"Navari","sequence":"first","affiliation":[{"name":"Comprehensive Cancer Center, University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron M.","family":"Pywell","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center, University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer G.","family":"Le-Rademacher","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"White","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Dodge","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantine","family":"Albany","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine, Indianapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Loprinzi","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"cbr200004r1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/cncr.24017","article-title":"Symptom distress, interventions, and outcomes of intensive care unit cancer patients referred to a palliative care consult team.","volume":"115","author":"Delgado-Guay","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"cbr200004r2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/jpm.2017.0159","article-title":"Pharmacovigilance in hospice\/palliative care: net effect of haloperidol for nausea or vomiting.","volume":"21","author":"Digges","year":"2018","journal-title":"J Palliat Med"},{"issue":"1","key":"cbr200004r3","first-page":"8","article-title":"Nausea and vomiting in advanced cancer: the Cleveland Clinic protocol.","volume":"11","author":"Gupta","year":"2013","journal-title":"J Support Oncol"},{"issue":"4","key":"cbr200004r4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jpainsymman.2004.01.009","article-title":"Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial.","volume":"28","author":"Bruera","year":"2004","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"cbr200004r5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/109662103764978506","article-title":"Olanzapine for intractable nausea in palliative care patients.","volume":"6","author":"Jackson","year":"2003","journal-title":"J Palliat Med"},{"issue":"6","key":"cbr200004r6","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1177\/1049909110369532","article-title":"Olanzapine for nausea and vomiting.","volume":"27","author":"Licup","year":"2010","journal-title":"Am J Hosp Palliat Care"},{"issue":"5","key":"cbr200004r7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0885-3924(03)00078-2","article-title":"A retrospective chart review of the use of olanzapine for the prevention of delayed emesis in cancer patients.","volume":"25","author":"Passik","year":"2003","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"cbr200004r8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S0885-3924(02)00391-3","article-title":"A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain.","volume":"23","author":"Passik","year":"2002","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"cbr200004r9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/(ISSN)1099-1611","article-title":"Remission of chemotherapy-induced emesis with concurrent olanzapine treatment: a case report.","volume":"9","author":"Pirl","year":"2000","journal-title":"Psychooncology"},{"issue":"6","key":"cbr200004r10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S0885-3924(03)00143-X","article-title":"Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer.","volume":"25","author":"Srivastava","year":"2003","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"cbr200004r11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jpainsymman.2011.10.023","article-title":"Olanzapine for the relief of nausea in patients with advanced cancer and incomplete bowel obstruction.","volume":"44","author":"Kaneishi","year":"2012","journal-title":"J Pain Symptom Manage"},{"issue":"8","key":"cbr200004r12","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s00520-018-4593-3","article-title":"Antiemetic use of olanzapine in patients with advanced cancer: results from an open-label multicenter study.","volume":"27","author":"Harder","year":"2019","journal-title":"Support Care Cancer"},{"issue":"1","key":"cbr200004r13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1089\/jpm.2015.0224","article-title":"Olanzapine in the management of difficult to control nausea and vomiting in a palliative care population: a case series.","volume":"19","author":"MacKintosh","year":"2016","journal-title":"J Palliat Med"},{"issue":"8","key":"cbr200004r14","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00520-009-0739-7","article-title":"Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial.","volume":"18","author":"Navari","year":"2010","journal-title":"Support Care Cancer"},{"issue":"2","key":"cbr200004r15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1056\/NEJMoa1515725","article-title":"Olanzapine for the prevention of chemotherapy-induced nausea and vomiting.","volume":"375","author":"Navari","year":"2016","journal-title":"N Engl J Med"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2765323\/jamaoncology_navari_2020_br_200004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T16:44:14Z","timestamp":1591893854000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2765323"}},"subtitle":["A Randomized Pilot Trial"],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2020.1052","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,1]]}}}